By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


European Commission (EC) 

Rue Joseph II
Jozef II straat 70
Brussels    B-1000  Belgium
Phone: n/a Fax: n/a


Medical Device

Company News
Swedish Orphan Biovitrum: European Commission (EC) Grants SOBI003 Orphan Designation For The Treatment Of MPS IIIA 10/19/2016 11:30:26 AM
SkylineDx And Consortium Of Leading European Partners Awarded Multi-Million Euro Horizon2020 Grant From European Commission (EC) 10/4/2016 11:02:20 AM
European Commission (EC) Approves Transfer Of Marketing Authorisation For Alprolix Sobi 10/3/2016 10:51:06 AM
European Commission (EC) Approves Ipsen (IPN.PA)’s Cabometyx (Cabozantinib) Tablets For The Treatment Of Advanced Renal Cell Carcinoma (RCC) In Adults Following Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Therapy 9/14/2016 10:22:59 AM
MeMed Diagnostics Release: €2.3 Million Award By European Commission (EC) Will Support Deployment Of Immunoxpert To Reduce Antibiotic Misuse In Hospitals 9/8/2016 11:27:14 AM
European Commission (EC) Approves Bristol-Myers Squibb (BMY)’s ORENCIA (Abatacept) For The Treatment Of Highly Active And Progressive Disease In Adult Patients With Rheumatoid Arthritis Not Previously Treated With Methotrexate 9/6/2016 11:40:36 AM
Alexion (ALXN) Release: European Commission (EC) Grants Orphan Drug Designation To ALXN1007 For The Treatment Of Patients With Graft-Versus-Host Disease (GVHD) 8/30/2016 11:41:00 AM
European Commission (EC) Grants Marketing Authorization For Gilead (GILD)’s Once-Daily Truvada® For Reducing The Risk Of Sexually Acquired HIV-1 8/22/2016 11:00:33 AM
European Commission (EC) Grants Marketing Authorization For Teva (TEVA)’s CINQAERO (Reslizumab) 8/18/2016 9:35:36 AM
Merck & Co. (MRK)’s KEYTRUDA (Pembrolizumab) Approved By The European Commission (EC) For Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Whose Tumors Express PD-L1 8/3/2016 9:43:46 AM